Free Trial
→ $2 Trillion Disappears Because of Fed's Secretive New Move (From Stansberry Research) (Ad) Buy REGN Stock  Free REGN Stock Alerts

Regeneron Pharmaceuticals (REGN) Short Interest Ratio & Short Volume

Regeneron Pharmaceuticals logo
$634.14 -26.86 (-4.06%)
Closing price 04:00 PM Eastern
Extended Trading
$634.99 +0.85 (+0.13%)
As of 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Regeneron Pharmaceuticals Short Interest Data

Regeneron Pharmaceuticals (REGN) has a short interest of 2.57 million shares, representing 2.54% of the float (the number of shares available for trading by the public). This marks a 16.82% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 635,607 shares to cover all short positions.

Current Short Interest
2,570,000 shares
Previous Short Interest
2,200,000 shares
Change Vs. Previous Month
+16.82%
Dollar Volume Sold Short
$1.80 billion
Short Interest Ratio
2.8 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
109,325,000 shares
Short Percent of Float
2.54%
Today's Trading Volume
852,346 shares
Average Trading Volume
635,607 shares
Today's Volume Vs. Average
134%
Short Selling Regeneron Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

REGN Short Interest Over Time

REGN Days to Cover Over Time

REGN Percentage of Float Shorted Over Time

Remove Ads

Regeneron Pharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/20252,570,000 shares $1.80 billion +16.8%2.5%2.8 $698.74
2/15/20252,200,000 shares $1.48 billion +0.5%2.2%2.5 $673.60
1/31/20252,190,000 shares $1.47 billion +3.3%N/A2.4 $672.98
1/15/20252,120,000 shares $1.49 billion +1.0%N/A2.4 $703.43
12/31/20242,100,000 shares $1.50 billion +11.7%N/A2.6 $712.33
12/15/20241,880,000 shares $1.37 billion +4.4%N/A2.2 $731.30
11/30/20241,800,000 shares $1.35 billion +0.6%N/A2.3 $750.22
11/15/20241,790,000 shares $1.35 billion -3.2%N/A2.5 $756.81
10/31/20241,850,000 shares $1.55 billion +7.6%N/A2.9 $838.20
10/15/20241,720,000 shares $1.75 billion -0.6%N/A3 $1,016.53
9/30/20241,730,000 shares $1.82 billion -12.6%N/A3.3 $1,051.24
9/15/20241,980,000 shares $2.28 billion -5.7%N/A4.1 $1,153.35
8/31/20242,100,000 shares $2.49 billion -0.5%N/A4.6 $1,184.69
8/15/20242,110,000 shares $2.48 billion +5.0%N/A4.7 $1,175.33
7/31/20242,010,000 shares $2.17 billion +6.4%N/A4.6 $1,079.19
7/15/20241,890,000 shares $2.05 billion -7.4%N/A4.3 $1,082.11
6/30/20242,040,000 shares $2.14 billion +10.3%N/A4.5 $1,051.03
6/15/20241,850,000 shares $1.92 billion +5.7%N/A4.1 $1,036.52
5/31/20241,750,000 shares $1.72 billion +7.4%N/A4 $980.16
5/15/20241,630,000 shares $1.59 billion +3.8%N/A3.7 $978.21
4/30/20241,570,000 shares $1.40 billion +13.0%N/A3.4 $890.66
4/15/20241,390,000 shares $1.25 billion -2.1%N/A3 $898.56
3/31/20241,420,000 shares $1.37 billion +2.2%N/A3 $962.49
3/15/20241,390,000 shares $1.34 billion +2.2%N/A2.7 $964.47
2/29/20241,360,000 shares $1.31 billion -0.7%N/A2.4 $966.09
2/15/20241,370,000 shares $1.31 billion +9.6%N/A2.4 $954.73
1/31/20241,250,000 shares $1.18 billion +16.8%N/A2.2 $942.78
1/15/20241,070,000 shares $998.52 million +0.9%1.0%1.9 $933.20
12/31/20231,060,000 shares $930.99 million -13.1%1.0%2 $878.29
12/15/20231,220,000 shares $1.05 billion -0.8%1.2%2.4 $859.14
11/30/20231,230,000 shares $1.01 billion -12.1%1.2%2.7 $823.81
11/15/20231,400,000 shares $1.11 billion +6.9%1.3%3.3 $792.38
10/31/20231,310,000 shares $1.02 billion -4.4%1.3%3 $779.89
10/15/20231,370,000 shares $1.15 billion +16.1%1.3%3 $839.63
9/30/20231,180,000 shares $971.09 million -18.6%1.1%2.4 $822.96
9/15/20231,450,000 shares $1.19 billion -2.0%1.4%2.5 $823.40
8/31/20231,480,000 shares $1.22 billion +8.8%1.4%2.5 $826.49
8/15/20231,360,000 shares $1.10 billion +1.5%1.3%2.1 $805.91
7/31/20231,340,000 shares $994.16 million +5.5%1.3%2.1 $741.91
7/15/20231,270,000 shares $912.52 million +17.6%N/A2 $718.52
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
6/30/20231,080,000 shares $776.02 million -12.2%N/A1.8 $718.54
6/15/20231,230,000 shares $963.18 million +7.9%N/A2.2 $783.07
5/31/20231,140,000 shares $838.54 million -5.8%N/A2 $735.56
5/15/20231,210,000 shares $908.66 million +2.5%N/A2.1 $750.96
4/30/20231,180,000 shares $946.11 million -2.5%1.1%2 $801.79
4/15/20231,210,000 shares $1.00 billion -6.9%1.2%2 $829.33
3/31/20231,300,000 shares $1.07 billion +7.4%1.2%2 $821.67
3/15/20231,210,000 shares $919.96 million +0.8%1.2%1.9 $760.30
2/28/20231,200,000 shares $912.50 million -10.5%1.2%1.9 $760.42
2/15/20231,340,000 shares $1.01 billion -8.2%1.3%2.1 $752.40
1/31/20231,460,000 shares $1.11 billion +3.6%1.4%2.2 $758.47
1/15/20231,410,000 shares $1.02 billion -6.0%1.4%2.2 $722.13
12/30/20221,500,000 shares $1.08 billion +4.2%1.5%2.2 $721.49
12/15/20221,440,000 shares $1.05 billion -7.1%1.4%2.1 $731.27
11/30/20221,550,000 shares $1.17 billion -11.9%1.5%2.1 $751.70
11/15/20221,760,000 shares $1.28 billion -0.6%1.7%2.3 $728.73
10/31/20221,770,000 shares $1.33 billion -16.1%1.7%2.3 $748.75
10/15/20222,110,000 shares $1.55 billion -7.5%2.1%2.8 $736.06
9/30/20222,280,000 shares $1.57 billion -3.8%2.2%3.2 $688.87
9/15/20222,370,000 shares $1.67 billion -18.6%2.3%3.5 $705.85
8/31/20222,910,000 shares $1.69 billion -0.7%2.8%4.3 $581.06
8/15/20222,930,000 shares $1.88 billion -4.6%2.9%4.6 $643.29
7/31/20223,070,000 shares $1.79 billion +7.3%3.0%4.6 $581.69
7/15/20222,860,000 shares $1.74 billion +3.3%2.8%4.3 $607.54
6/30/20222,770,000 shares $1.64 billion +7.4%N/A4.1 $591.13
6/15/20222,580,000 shares $1.45 billion +23.4%N/A3.7 $561.19
5/31/20222,090,000 shares $1.39 billion -4.1%N/A3.1 $664.74
5/15/20222,180,000 shares $1.41 billion +0.9%N/A3.4 $645.52
4/30/20222,160,000 shares $1.42 billion +0.5%N/A3.2 $659.11
4/15/20222,150,000 shares $1.58 billion -2.3%2.1%3 $733.02
3/31/20222,200,000 shares $1.54 billion -8.0%2.1%3 $698.42
3/15/20222,390,000 shares $1.59 billion +6.7%2.3%3.3 $665.93
2/28/20222,240,000 shares $1.39 billion +4.7%2.2%3 $618.36
2/15/20222,140,000 shares $1.35 billion +19.6%2.1%2.8 $630.15
1/31/20221,790,000 shares $1.09 billion -1.7%1.7%2.4 $608.59
1/15/20221,820,000 shares $1.12 billion +11.0%1.8%2.4 $615.24
12/31/20211,640,000 shares $1.04 billion +7.2%1.6%2.2 $631.52
12/15/20211,530,000 shares $1.01 billion +3.4%1.5%1.9 $657.93
11/30/20211,480,000 shares $942.06 million -8.1%1.4%2 $636.53
11/15/20211,610,000 shares $1.04 billion -14.4%1.6%2.1 $647.73
10/29/20211,880,000 shares $1.20 billion +6.8%1.8%2.3 $639.94
10/15/20211,760,000 shares $973.70 million -2.2%1.7%2.2 $553.24
9/30/20211,800,000 shares $1.09 billion +14.7%1.8%2.4 $605.18
9/15/20211,570,000 shares $1.02 billion +15.4%1.5%2 $652.00
8/31/20211,360,000 shares $915.82 million -3.6%1.3%1.7 $673.40
8/13/20211,410,000 shares $880.95 million -11.3%1.4%1.8 $624.79
7/30/20211,590,000 shares $913.63 million -13.6%1.6%2.1 $574.61
7/15/20211,840,000 shares $1.08 billion +30.5%1.8%2.4 $589.32
6/30/20211,410,000 shares $787.54 million -26.6%1.4%1.8 $558.54
6/15/20211,920,000 shares $1.01 billion -9.0%1.9%2.4 $527.49
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
5/28/20212,110,000 shares $1.06 billion -5.4%2.1%2.6 $502.43
5/14/20212,230,000 shares $1.15 billion -4.7%2.2%2.6 $517.17
4/30/20212,340,000 shares $1.13 billion -14.9%2.3%2.5 $485.00
4/15/20212,750,000 shares $1.32 billion +24.4%2.7%2.8 $481.16
3/31/20212,210,000 shares $1.04 billion -16.9%2.2%2.1 $470.67
3/15/20212,660,000 shares $1.25 billion +14.7%2.6%2.6 $471.46
2/26/20212,320,000 shares $1.05 billion +10.0%2.3%2.2 $453.19
2/12/20212,110,000 shares $1.04 billion +8.8%2.1%2 $490.54
1/29/20211,940,000 shares $982.16 million -18.8%1.9%2 $506.27
1/15/20212,390,000 shares $1.24 billion +6.2%2.4%2.6 $517.91
12/31/20202,250,000 shares $1.08 billion +14.8%2.2%2.4 $478.30
12/15/20201,960,000 shares $980.74 million -8.0%1.9%1.9 $500.38
11/30/20202,130,000 shares $1.09 billion +6.0%2.1%2.2 $514.05
11/15/20202,010,000 shares $1.14 billion -7.4%2.0%2.1 $566.43
10/30/20202,170,000 shares $1.21 billion -6.9%2.1%2.4 $555.79
10/15/20202,330,000 shares $1.40 billion +13.7%2.3%2.7 $600.82
9/30/20202,050,000 shares $1.15 billion +28.1%2.0%2.4 $559.78
9/15/20201,600,000 shares $927.84 million +0.6%1.6%2.1 $579.90
8/31/20201,590,000 shares $985.69 million -0.6%1.6%2 $619.93
8/14/20201,600,000 shares $980.11 million -15.3%1.6%1.4 $612.57
7/31/20201,890,000 shares $1.19 billion -5.0%1.9%1.5 $632.07
7/15/20201,990,000 shares $1.28 billion -6.1%1.9%1.5 $641.23
6/30/20202,120,000 shares $1.32 billion -14.2%2.0%1.5 $623.65
6/15/20202,470,000 shares $1.46 billion +24.1%2.3%1.7 $590.57
5/29/20201,990,000 shares $1.22 billion +11.8%1.9%1.3 $612.81
5/15/20201,780,000 shares $1.03 billion -4.8%2.1%1.2 $576.72
4/30/20201,870,000 shares $983.40 million -7.0%2.2%1.4 $525.88
4/15/20202,010,000 shares $1.03 billion +12.9%2.5%1.5 $511.69
3/31/20201,780,000 shares $1.01 billion -30.4%2.2%1.4 $566.21

REGN Short Interest - Frequently Asked Questions

What is Regeneron Pharmaceuticals' current short interest?

Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 2,570,000 shares of REGN short. 2.54% of Regeneron Pharmaceuticals' shares are currently sold short. Learn More on Regeneron Pharmaceuticals' current short interest.

What is a good short interest ratio for Regeneron Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REGN shares currently have a short interest ratio of 3.0. Learn More on Regeneron Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Regeneron Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Shufro Rose & Co. LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Point72 Asset Management L.P., Nomura Holdings Inc., Millennium Management LLC, Laurion Capital Management LP, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cresset Asset Management LLC, Cubist Systematic Strategies LLC, Caption Management LLC, Centiva Capital LP, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, Hsbc Holdings PLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Capula Management Ltd, National Bank of Canada FI, JPMorgan Chase & Co., Mirae Asset Securities USA Inc., Simplex Trading LLC, NINE MASTS CAPITAL Ltd, Garda Capital Partners LP, Allianz Asset Management GmbH, Covenant Asset Management LLC, IMC Chicago LLC, XR Securities LLC, SG Americas Securities LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Regeneron Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.54% of Regeneron Pharmaceuticals' floating shares are currently sold short.

Is Regeneron Pharmaceuticals' short interest increasing or decreasing?

Regeneron Pharmaceuticals saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 2,570,000 shares, an increase of 16.8% from the previous total of 2,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Regeneron Pharmaceuticals' short interest compare to its competitors?

2.54% of Regeneron Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Regeneron Pharmaceuticals: Amgen Inc. (3.01%), Gilead Sciences, Inc. (1.82%), Vertex Pharmaceuticals Incorporated (2.14%), Alnylam Pharmaceuticals, Inc. (1.95%), Biogen Inc. (2.55%), United Therapeutics Co. (5.58%), BioMarin Pharmaceutical Inc. (2.27%), Incyte Co. (3.07%), Neurocrine Biosciences, Inc. (3.39%), Exelixis, Inc. (4.89%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

What does it mean to sell short Regeneron Pharmaceuticals stock?

Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. REGN shares are trading up $2.52 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Regeneron Pharmaceuticals?

A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further.

How often is Regeneron Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is February, 28 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:REGN) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored